KP
Kala Pharmaceuticals Inc
🇺🇸XNAS.KALAUnited StatesHealthcare
$0.51USDdown -0.04 (-7.27%)OpenDelayed5:08 PM
Price$0.51-0.04 (-7.27%)
Profile
- Healthcare
- Biotechnology
- United States
Identity
- Exchange
- Nasdaq . XNAS
- Type
- Stock
- ISIN
- US4831193010
- CUSIP
- 483119103
Company
- Employees
- 6
- Headquarters
- Arlington, United States
- Website
- https://www.kalarx.com
- CEO
- Mr. Avi Minkowitz
Market
- Shares outstanding
- 19.3M
- Market cap
- $9.86M
Highlights
- Market cap
- $9.86M
- EPS LTM
- -$0.52calculatedCalculated by Finzer, not reported by the data provider.
- P/E LTM
- -0.98calculatedCalculated by Finzer, not reported by the data provider.
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $0-100%down year on year
- Net income
- -$10.08M+72.92%up year on year
- Gross margin
- Not reported
- Free cash flow
- -$19.85M+23.37%up year on year
Other listings
- XFRA.27F0Frankfurt Stock Exchange
- XSTU.27F0Stuttgart Stock Exchange
- XMUN.27F0Munich Stock Exchange
- XDUS.27F0Düsseldorf Stock Exchange
- XBER.27F0Berlin Stock Exchange
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.